Healthcare & Biotech

North Chicago, Ill. – September 07, 2026 -- Allergan Aesthetics, an AbbVie company, has released a global study of more than 12,000 beauty-involved consumers across nine markets showing a decisive shift away from one-time aesthetic procedures toward personalized, long-term treatment plans.

Global survey data points to a structural change in patient demand patterns

The Layered Beauty: The New Aesthetic Mindset report, based on the 12,000-consumer dataset combined with practitioner input and regional analysis, finds patients increasingly expect multimodal treatment strategies that evolve with their goals and life stages rather than single-session fixes.

Skin quality now anchors broader aesthetic and wellness spending

Respondents identified skin quality as the foundation of aesthetic care, integrating treatments into wider beauty and wellness routines rather than treating them as isolated interventions.

San Francisco – September 07, 2026 -- Rainfall Health announced that Mayo Clinic in Jacksonville, Florida will deploy its AI-driven platform to manage care coordination and compliance under the Centers for Medicare & Medicaid Services' Transforming Episode Accountability Model (TEAM), a mandatory payment program that took effect January 1, 2026.

CMS mandates 721 hospitals into value-based surgical episode program

CMS selected 721 hospitals for the first TEAM cohort, requiring value-based reimbursement across five high-volume surgical episodes. Hospitals missing cost and quality benchmarks face financial penalties, while those that meet targets can access reconciliation bonuses worth up to $85 million in new revenue.

New York – September 07, 2026 -- Bayesian Health has secured a New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services, making it the first continuous sepsis monitoring technology to hold both FDA clearance and a dedicated Medicare reimbursement pathway.

The approval, issued under CMS's FY 2027 Inpatient Prospective Payment System Final Rule, takes effect October 1, 2026, and allows hospitals using Bayesian's FDA-cleared sepsis flagging device to bill Medicare an add-on payment of up to $61.84 per eligible inpatient case.

Austin, Texas – September 7, 2026 -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has become the first center in the United States to enroll a patient in a clinical trial evaluating a next-generation pulsed field ablation mapping and ablation system for paroxysmal and persistent atrial fibrillation.

TCAI performs first US procedure under global trial protocol

Andrea Natale, M.D., executive medical director of TCAI and global principal investigator for the trial, performed the inaugural procedure. The study is designed to assess the safety and efficacy of the catheter-based system in patients with paroxysmal atrial fibrillation, defined as symptomatic episodes lasting seven days or less, and persistent atrial fibrillation, sustained arrhythmia lasting longer than one week.

Arlington, Va. – – September 07, 2026 -- An independent review by the American Diabetes Association's Audit and Governance Committee (AGC) has concluded that five attendees removed from the 2026 Scientific Sessions in New Orleans on June 5 were expelled for disruptive conduct, not for the content of materials they were distributing.

Committee interviewed 28 witnesses over nearly three months

The AGC, composed of volunteer investigators drawn from clinicians, people with diabetes, healthcare providers and business leaders aligned with the ADA, conducted its inquiry over a near three-month period. Investigators interviewed 28 individuals with firsthand knowledge of the June 5 events, including the five attendees who were removed, and reviewed videos, emails, text messages, news articles and published editorials.

New Haven, Connecticut – September 07, 2026 -- Yale School of Medicine (YSM) has secured close to $25 million in research funding from the Aligning Research to Impact Autism (ARIA) program, part of ARIA's Human Neurodevelopment Research Centers initiative. The funding will support efforts to build a foundational atlas and model of human brain development, pinpointing when autism-related developmental differences first emerge and how they diverge from typical developmental trajectories.

San Diego – September 07, 2026 -- Lighteum Medical has appointed Gaurav Agarwal as Chief Executive Officer, effective August 31, 2026, bringing nearly 30 years of medtech leadership to the precision component manufacturer.

Agarwal joins with a track record of over $15 billion in M&A activity and $11 billion in private equity dispositions

Agarwal most recently served as President and CEO of PE-backed Capsa Healthcare, where he delivered more than 20% revenue and EBITDA growth within 18 months, completed two tuck-in acquisitions, and expanded the company into software and services. He previously led Vyaire Medical as President and CEO, and held senior roles at Acelity/KCI, Smith & Nephew, and GE Healthcare. At Acelity/KCI, he oversaw global commercial operations during a portfolio transformation that preceded the company's $6.725 billion sale to 3M.

Kansas City, Mo. and Seattle – September 05, 2026 -- SmartConnect Medicare Business Solutions and Benepicks have launched a nationwide partnership that embeds Medicare guidance directly into Benepicks' ICHRA platform, with employers averaging a 15% reduction in healthcare spending, according to recent data cited by the companies.

Standard ICHRA platforms leave 65-plus employees without Medicare support, companies say

Most individual coverage HRA (ICHRA) platforms are built for Marketplace insurance shopping, leaving Medicare-eligible workers to navigate enrollment deadlines and plan selection alone. The gap has produced costly errors for employees, administrative bottlenecks for HR teams, and friction for benefits brokers as employer adoption of ICHRAs accelerates amid rising healthcare costs.

Madrid – September 04, 2026 -- Monteloeder, SL, a subsidiary of SuanNutra, SA, has published preclinical data showing its nutricosmetic ingredient Elissara® increases human dermal papilla cell proliferation to roughly 2.5 times that of untreated controls, extending the compound's known scalp benefits into follicular biology.

Sheridan, Wyoming – September 04, 2026 -- VALOR Network Inc., a Service-Disabled Veteran-Owned Small Business, has selected RADIN Health's cloud-based radiology platform to power teleradiology services for the U.S. Department of Veterans Affairs and Department of War, with Total Medical Imaging supplying nationwide physician coverage through its network of more than 60 board-certified radiologists.

VALOR taps RADIN's secure cloud platform for federal imaging workflow

RADIN will deploy its radiology platform within a secure government-cloud environment built to meet federal healthcare security and operational requirements. The platform integrates enterprise imaging, PACS, RIS, intelligent worklists, diagnostic reporting, clinical communications, workflow automation, analytics and AI-assisted tools in a single system.